Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NRXS is expected to report earnings to rise 9.09% to -23 cents per share on November 24
Q3'25
Est.
$-0.24
Q2'25
Beat
by $0.03
Q4'24
Missed
by $0.27
Q1'24
Missed
by $0.22
Q3'23
Missed
by $1.18
The last earnings report on August 12 showed earnings per share of -21 cents, beating the estimate of -25 cents. With 16.61K shares outstanding, the current market capitalization sits at 24.27M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NRXS showed earnings on August 12, 2025. You can read more about the earnings report here.